American Preclinical Services, Now Part of NAMSA

Research ServicesMinnesota, United States51-200 Employees

American Preclinical Services (APS), now part of NAMSA, operates as a contract research organization focused on preclinical testing for medical devices and pharmaceuticals. Based in Minneapolis, Minnesota, APS maintains accreditations and registrations including AAALAC, ISO17025, USDA, and GLP compliance, supporting a broad range of biocompatibility, toxicology, pharmacology, and pathology services. The company positions itself as a center of excellence with capabilities spanning interventional, surgical, and bioskills activities, along with animal model development and comprehensive pathology, aimed at advancing product development timelines for both startups and established industry players. Its value lies in delivering rapid, flexible study design and execution from initial feasibility and screening through GLP safety studies, aligning with the fast-paced demands of product development. A notable recent development includes a collaboration with Recombinetics in 2020 to pursue a glioblastoma-related study, illustrating engagement with partners on specialized preclinical research.

Sign up for free to view info

Email Format Employee directory